180 Life SciencesのQuick ratio

180 Life SciencesのQuick ratioは何ですか。

180 Life Sciences Corp.のQuick ratioは0.58です。

Quick ratioの定義は何ですか。



当座比率は、短期債務を即座に満たすために迅速な資産を使用する企業の能力を測定する流動性比率です。

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

NASDAQのセクタHealth CareにおけるQuick ratioの企業と比べる180 Life Sciences

180 Life Sciencesは何をしますか。

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

180 Life Sciencesと類似のquick ratio